Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Xiaohui Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4783-2926; OpenAlex author ID A5101785911. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2015: 4 papers · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers

Papers 13

  1. Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81]. Co-author DOI 10.1016/j.canlet.2022.215836↗
  2. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in … Co-author DOI 10.1016/j.canlet.2022.215859↗
  3. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practic… Co-author DOI 10.3748/wjg.v25.i1.138↗
  4. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-017-0052-1↗
  5. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13351↗
  6. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Co-author DOI 10.1016/j.canlet.2017.09.019↗
  7. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Co-author DOI 10.1038/cddiscovery.2017.4↗
  8. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1. Co-author DOI 10.1007/s13277-015-4234-0↗
  9. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-rela… Co-author DOI 10.1016/j.canlet.2015.12.010↗
  10. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00125-014-3481-8↗
  11. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. First author DOI 10.1186/s12967-015-0442-z↗
  12. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-015-0490-4↗
  13. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy. Co-author DOI 10.18632/oncotarget.5150↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shangyou Zheng · 11 shared papers, 2015–2022 · strength 0.74
  2. Quanbo Zhou · 10 shared papers, 2015–2022 · strength 0.66
  3. Yimin Liu · 10 shared papers, 2015–2022 · strength 0.65
  4. Huilin Ye · 9 shared papers, 2015–2022 · strength 0.61
  5. Zhiqiang Fu · 9 shared papers, 2015–2022 · strength 0.57
  6. Rufu Chen · 8 shared papers, 2015–2022 · strength 0.51
  7. Wenzhu Li · 7 shared papers, 2015–2022 · strength 0.46
  8. Yingxue Wang · 6 shared papers, 2015–2022 · strength 0.40
  9. Wenchao Gao · 7 shared papers, 2015–2022 · strength 0.39
  10. Zhihua Li · 5 shared papers, 2015–2022 · strength 0.33
  11. Yuming Luo · 4 shared papers, 2016–2022 · strength 0.30
  12. Huimou Chen · 4 shared papers, 2015–2022 · strength 0.26
  13. Yue Zhao · 3 shared papers, 2017–2022 · strength 0.25
  14. Langping Tan · 3 shared papers, 2015–2022 · strength 0.21
  15. Changhao Chen · 2 shared papers, 2017–2022 · strength 0.19
  16. Zhihua Li · 2 shared papers, 2018–2019 · strength 0.18
  17. Guolin Li · 3 shared papers, 2016–2018 · strength 0.18
  18. Yanhui Jiang · 3 shared papers, 2016–2018 · strength 0.17
  19. Rufu Chen · 2 shared papers, 2015–2022 · strength 0.16
  20. Lusheng Wei · 2 shared papers, 2017–2018 · strength 0.13
  21. Yu Zhou · 2 shared papers, 2015 · strength 0.09
  22. Chen Rufu · 1 shared paper, 2018 · strength 0.07
  23. Yibiao Ye · 1 shared paper, 2015 · strength 0.05
  24. Doudou Li · 1 shared paper, 2015 · strength 0.04
  25. Jin-Long Zeng · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.